CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Jayesh Mehta

doi:10.1056/NEJMc2103481

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Jayesh Mehta

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	e91
Journal	The New England journal of medicine
Volume	384
Issue number	23
DOIs	https://doi.org/10.1056/NEJMc2103481
State	Published - Jun 10 2021

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc2103481

Cite this

@article{b592a2da3cc044188af66601ff2bffb1,

title = "CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia",

author = "Jayesh Mehta",

year = "2021",

month = jun,

day = "10",

doi = "10.1056/NEJMc2103481",

language = "English (US)",

volume = "384",

pages = "e91",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "23",

}

TY - JOUR

T1 - CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

AU - Mehta, Jayesh

PY - 2021/6/10

Y1 - 2021/6/10

UR - http://www.scopus.com/inward/record.url?scp=85107995312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107995312&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2103481

DO - 10.1056/NEJMc2103481

M3 - Letter

C2 - 34107196

AN - SCOPUS:85107995312

SN - 0028-4793

VL - 384

SP - e91

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 23

ER -

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this